20 Questions to Ask Your Doctor About Recurrent Ovarian Cancer

Hearing that your ovarian cancer has returned can feel overwhelming. The uncertainty, the fear, the questions: they all come rushing back. 

But this time, you’re not starting from scratch. You have experience navigating this disease, and you know that asking the right questions can make all the difference in understanding your path forward.

Your doctor is your partner in this journey, but they can’t read your mind. The questions you ask during appointments shape the care you receive. Whether you’re newly diagnosed with a recurrence or preparing for that possibility, this list will help you have more productive conversations with your oncology team.

Understanding Your Recurrence

Before you can move forward with treatment, you need a clear picture of what’s happening in your body right now. These foundational questions help you and your doctor establish the basic facts about your recurrence and gather information that will guide every decision that follows.

1. Is this definitely a recurrence, or could it be a new cancer?

This distinction matters more than you might think. Ovarian cancer recurrence means the original cancer has returned, while a new cancer would be an entirely different disease requiring different treatment. Your doctor will likely confirm this through tissue analysis, but it’s worth asking directly so you understand what you’re facing.

2. Where has the cancer recurred?

Location matters enormously in treatment planning. Ovarian cancer most commonly recurs in the pelvis or abdomen, but it can also appear in lymph nodes, the liver, or lungs.

Worth knowing: not all recurrences are confirmed by imaging. Some gynecologic oncologists will treat based on what’s called a biochemical recurrence. 

This means that your tumor marker (usually CA-125, or whichever marker your team has been following) has risen significantly enough to indicate the cancer is active, even if imaging hasn’t yet confirmed a visible site. Ideally, a PET scan would follow to pinpoint the location, but that’s not always possible due to insurance coverage or other barriers.

Understanding how your recurrence was identified — and where it is, if known — helps you grasp why certain treatments are being recommended over others.

3. Is my recurrence platinum-sensitive, platinum-resistant, or platinum-refractory?

This classification is crucial because it tells your doctor whether the same chemotherapy drugs that worked before are likely to work again. The terms refer to how your cancer responds to platinum-based chemotherapy drugs like carboplatin.

Here’s how doctors categorize recurrence based on timing:

If your cancer returns 6 months or more after finishing platinum treatment, it’s considered “platinum-sensitive,” meaning those drugs will likely be effective again. Some doctors break this down further: recurrence between 6 and 12 months is “partially platinum-sensitive,” while recurrence after 12 months is “fully platinum-sensitive.”

If your cancer returns within 6 months, it’s “platinum-resistant,” and your doctor will recommend different ovarian cancer treatment options.

Within this category, there’s an important distinction you may hear: platinum-refractory disease, which refers to cancer that progresses during treatment or returns very shortly after. 

But here’s where it gets complicated: there is no universally standardized definition of this term. The NCI and some researchers define it as progression within 4 weeks of completing platinum therapy. The Gynecologic Cancer InterGroup consensus uses a cutoff of 12 weeks. 

Notably, the NCCN guidelines don’t use the term “refractory” at all. Instead, they classify any progression on therapy, stable or persistent disease, or relapse within 6 months of chemotherapy completion under the broader umbrella of platinum resistance.

What this means practically: if your doctor uses the word “refractory,” it’s worth asking exactly what they mean by it, because the definition can vary depending on which guidelines or research framework they’re working from.

The key factor here is your platinum-free interval: the amount of time between your last platinum treatment and when the cancer returns. This timeframe directly influences your treatment plan. 

Some researchers view platinum sensitivity as a continuum rather than strict categories, but understanding where you fall on this spectrum helps explain why your doctor is recommending certain treatments over others.

Treatment Options and Approach

Once you understand the nature of your recurrence, the conversation shifts to action. Treatment for recurrent ovarian cancer looks different than initial treatment, and you have more options available than you might realize. 

These questions help you explore every possibility and understand why your doctor recommends certain approaches over others.

4. What are all my treatment options for this recurrence?

Don’t settle for hearing about just one approach. Ask your oncologist to walk you through every option available to you: chemotherapy, targeted therapies, surgery, ovarian cancer clinical trials, or a combination. 

Each option comes with different benefits, side effects, and time commitments. You deserve to know the full plan before making decisions.

5. Why are you recommending this specific treatment plan?

Understanding the “why” behind your doctor’s recommendations helps you feel more confident in your treatment decisions. Is it because of your cancer’s biomarkers? Your previous treatment response? Your overall health? The more you understand their reasoning, the better equipped you are to weigh your options.

6. Are there any clinical trials I might be eligible for?

Ovarian cancer clinical trials give you access to cutting-edge treatments that aren’t yet widely available. Many women don’t realize they might qualify for trials, so it’s always worth asking. Your doctor can explain what trials are available and whether they might offer advantages over standard treatment.

7. Could surgery be an option for me?

Not every recurrence requires surgery, but in some cases, particularly when the cancer has returned to a single location and it’s been a while since your last treatment, surgical debulking might be considered. 

Ask your doctor whether this applies to your situation and what the risks and benefits would be.

8. What are the potential side effects of the recommended treatment?

You’ve been through treatment before, so you know side effects are part of the equation. But different treatments cause different side effects. Ask specifically about what to expect, how those side effects can be managed, and whether they’re temporary or permanent. This information is essential for planning your life during treatment.

Testing and Monitoring

Managing ovarian cancer recurrence means staying vigilant about how your body responds to treatment. The right monitoring plan catches problems early and helps your medical team adjust your care when needed. Don’t leave your appointments without understanding exactly how and when you’ll be evaluated.

9. What tests will you use to monitor my cancer during and after treatment?

Understanding your monitoring plan helps you know what to expect at follow-up appointments. Will it be imaging scans, CA-125 blood tests, physical exams, or a combination? How often will these tests happen?

The CA-125 blood test is commonly used to track ovarian cancer, but it’s important to understand its limitations.

10. Should I have genetic or biomarker testing done again?

This is worth asking, but the answer depends on what type of testing you’re talking about, and it’s a distinction that trips up a lot of patients.

Germline genetic testing is a blood test that looks at your inherited DNA — the genetic material in every cell of your body — for mutations like BRCA1 or BRCA2. Because your inherited DNA doesn’t change, this test doesn’t need to be repeated if you already had it at diagnosis. If you never had it done, though, now is the time to ask.

Tumor molecular testing (sometimes called somatic testing) is different. This looks at the DNA of your actual cancer cells — mutations that exist only in the tumor, not throughout your body. 

The NCCN recommends tumor molecular testing at recurrence if it wasn’t done previously. And even if it was done before, repeat testing may be worthwhile: tumors can evolve over time, and years later there may be new targets or new drugs that simply didn’t exist at your original diagnosis. 

For example, folate receptor alpha is now showing promise as a target in recurrent epithelial ovarian cancer: a test that wasn’t routinely done in years past. Repeat molecular testing can also open doors to clinical trial eligibility.

So the short version: no need to repeat germline genetic testing if it’s already been done, but yes to tumor molecular testing at recurrence, especially if it’s been a while.

11. How will we know if the treatment is working?

Ask your doctor to explain what success looks like. Will it be shrinking tumors on scans, dropping CA-125 levels, or absence of new symptoms? Understanding the benchmarks helps you track your progress and know what changes warrant contacting your medical team.

Quality of Life and Support

Treatment isn’t just about attacking cancer cells; it’s about maintaining the best possible quality of life while you’re doing it. These questions acknowledge that you’re a whole person, not just a patient, and that your physical comfort and emotional wellbeing matter just as much as your scan results.

12. How will this treatment affect my daily life?

This is where honesty matters most. Will you be able to work during treatment? Exercise? Travel? Understanding the practical impacts helps you plan and adjust your expectations. Don’t be shy about asking these questions; your quality of life matters just as much as treatment outcomes.

13. What symptoms should I watch for and report immediately?

Not every symptom requires a call to your doctor, but some do. Ask specifically what warning signs you should never ignore. This knowledge empowers you to respond quickly if something concerning develops.

Learn more: “Emergency Care for Ovarian Cancer: When to Call Your Doctor”

14. What supportive care options are available to me?

Palliative care for ovarian cancer isn’t just for end-of-life situations. Research shows that people who receive palliative care during recurrent cancer treatment often experience better quality of life, fewer symptoms, and even longer survival. Ask about palliative care specialists, pain management, nutritional support, and mental health resources.

15. Can you recommend support groups or resources for people facing recurrence?

Connecting with others who understand what you’re going through can be incredibly valuable. Ask your doctor about local or online ovarian cancer support groups specifically for people with recurrent ovarian cancer. Many hospitals and cancer centers offer these resources.

Prognosis and Planning

These are the hardest questions to ask: the ones about the future and what it might hold. There’s no right or wrong approach here. Some people need to know the numbers and possibilities, while others prefer to focus on the present. Either way is valid, but if you do want to discuss prognosis, these questions can guide that conversation.

16. What is my prognosis with this recurrence?

This is one of the hardest questions to ask, but many patients want to know. Remember that statistics are just numbers: they can’t predict what will happen to you specifically. Your doctor can give you general information while acknowledging the uncertainty. It’s okay if you’d rather not know specific numbers; let your doctor know your preference.

17. If this treatment doesn’t work, what comes next?

Planning for multiple scenarios doesn’t mean giving up hope. It means being prepared. Understanding what options exist if your first-line treatment for recurrence doesn’t work as hoped can reduce anxiety and help you feel more in control.

18. What does “living with ovarian cancer as a chronic disease” mean for me?

Many women with recurrent ovarian cancer go through cycles of treatment and remission, sometimes for years. Understanding how to think about ovarian cancer as a manageable chronic condition — rather than something that must be cured immediately — can shift your perspective and help you plan for the future.

Second Opinions and Specialized Care

Getting the best possible care sometimes means seeking additional expertise. These questions help you determine whether you’re in the right hands or if you might benefit from consulting with additional specialists. Most doctors appreciate patients who advocate for themselves. It’s a sign you’re engaged in your care.

19. Would you recommend I get a second opinion?

Most doctors welcome second opinions and won’t be offended if you ask. In fact, seeking another expert’s perspective can provide reassurance that you’re on the right track or reveal additional options you hadn’t considered.

20. Should I be seeing a gynecologic oncologist?

If you’re not already under the care of a gynecologic oncologist, a doctor who specializes specifically in cancers of the female reproductive system, ask whether you should be. Studies consistently show that women treated by gynecologic oncologists have better outcomes than those treated by general oncologists or surgeons. 

Moving Forward with Confidence

Asking questions doesn’t mean you doubt your doctor’s expertise. It means you’re an active participant in your care. The best medical teams encourage questions because informed patients make better partners in treatment decisions.

Bring this list to your next appointment. Write down additional questions as they come to you. Don’t worry about asking something that seems “too simple” or “too complicated.” Every question that helps you understand your situation better is a question worth asking. And, as always, advocate for your needs and remember that knowledge is power in the face of recurrence.